Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ghaith Aljayyoussi

Showing results (11-20 of 41) with videos related to

Pageof 5
Sort By:
International Journal of Pharmaceutics|March 6, 2020
Auto-fluorescent PAMAM-based dendritic molecules and their potential application in pharmaceutical sciencesAlaa M M El-Betany, Elbadawy A Kamoun, Craig James, et al.
Scientific Reports|January 27, 2022
SARS-CoV-2 viability on sports equipment is limited, and dependent on material compositionThomas Edwards, Grant A Kay, Ghaith Aljayyoussi, et al.
Antimicrobial Agents and Chemotherapy|October 5, 2016
Population Pharmacokinetics of Liposomal Amphotericin B in Immunocompromised ChildrenJodi M Lestner, Andreas H Groll, Ghaith Aljayyoussi, et al.
BMJ Open Respiratory Research|March 23, 2025
Head-to-head comparison of anterior nares and nasopharyngeal swabs for SARS-CoV-2 antigen detection in a community drive-through test centre in the UKRachel L Byrne, Ghaith Aljayyoussi, Konstantina Kontogianni, et al.
Plos Neglected Tropical Diseases|December 27, 2019
Treatment responses to Azithromycin and Ciprofloxacin in uncomplicated Salmonella Typhi infection: A comparison of Clinical and Microbiological Data from a Controlled Human Infection ModelCelina Jin, Malick M Gibani, Shaun H Pennington, et al.
JMIR Research Protocols|November 19, 2016
Efficacy and Safety of High-Dose Ivermectin for Reducing Malaria Transmission (IVERMAL): Protocol for a Double-Blind, Randomized, Placebo-Controlled, Dose-Finding Trial in Western KenyaMenno R Smit, Eric Ochomo, Ghaith Aljayyoussi, et al.
Pharmaceuticals (Basel, Switzerland)|April 3, 2023
The Parasite Reduction Ratio (PRR) Assay Version 2: Standardized Assessment of <i>Plasmodium falciparum</i> Viability after Antimalarial Treatment In VitroAnnabelle Walz, Maëlle Duffey, Ghaith Aljayyoussi, et al.
Science Translational Medicine|March 26, 2025
<i>Anopheles</i> mosquito survival and pharmacokinetic modeling show the mosquitocidal activity of nitisinoneLee R Haines, Anna Trett, Clair Rose, et al.
Microbiology Spectrum|August 13, 2025
Comparison of the analytical and clinical sensitivities of 34 rapid antigen tests with prevalent SARS-CoV-2 variants of concern during the COVID-19 pandemic in the UKRachel L Byrne, Rachel S Owen, Ghaith Aljayyoussi, et al.
ACS Infectious Diseases|December 22, 2020
Therapeutic Potential of Nitazoxanide: An Appropriate Choice for Repurposing versus SARS-CoV-2?Andrew V Stachulski, Joshua Taujanskas, Sophie L Pate, et al.
Pageof 5

Showing results (11-20 of 41) with videos related to

Sort By:
Pageof 5
International Journal of Pharmaceutics|March 6, 2020
Auto-fluorescent PAMAM-based dendritic molecules and their potential application in pharmaceutical sciencesAlaa M M El-Betany, Elbadawy A Kamoun, Craig James, et al.
Scientific Reports|January 27, 2022
SARS-CoV-2 viability on sports equipment is limited, and dependent on material compositionThomas Edwards, Grant A Kay, Ghaith Aljayyoussi, et al.
Antimicrobial Agents and Chemotherapy|October 5, 2016
Population Pharmacokinetics of Liposomal Amphotericin B in Immunocompromised ChildrenJodi M Lestner, Andreas H Groll, Ghaith Aljayyoussi, et al.
BMJ Open Respiratory Research|March 23, 2025
Head-to-head comparison of anterior nares and nasopharyngeal swabs for SARS-CoV-2 antigen detection in a community drive-through test centre in the UKRachel L Byrne, Ghaith Aljayyoussi, Konstantina Kontogianni, et al.
Plos Neglected Tropical Diseases|December 27, 2019
Treatment responses to Azithromycin and Ciprofloxacin in uncomplicated Salmonella Typhi infection: A comparison of Clinical and Microbiological Data from a Controlled Human Infection ModelCelina Jin, Malick M Gibani, Shaun H Pennington, et al.
JMIR Research Protocols|November 19, 2016
Efficacy and Safety of High-Dose Ivermectin for Reducing Malaria Transmission (IVERMAL): Protocol for a Double-Blind, Randomized, Placebo-Controlled, Dose-Finding Trial in Western KenyaMenno R Smit, Eric Ochomo, Ghaith Aljayyoussi, et al.
Pharmaceuticals (Basel, Switzerland)|April 3, 2023
The Parasite Reduction Ratio (PRR) Assay Version 2: Standardized Assessment of <i>Plasmodium falciparum</i> Viability after Antimalarial Treatment In VitroAnnabelle Walz, Maëlle Duffey, Ghaith Aljayyoussi, et al.
Science Translational Medicine|March 26, 2025
<i>Anopheles</i> mosquito survival and pharmacokinetic modeling show the mosquitocidal activity of nitisinoneLee R Haines, Anna Trett, Clair Rose, et al.
Microbiology Spectrum|August 13, 2025
Comparison of the analytical and clinical sensitivities of 34 rapid antigen tests with prevalent SARS-CoV-2 variants of concern during the COVID-19 pandemic in the UKRachel L Byrne, Rachel S Owen, Ghaith Aljayyoussi, et al.
ACS Infectious Diseases|December 22, 2020
Therapeutic Potential of Nitazoxanide: An Appropriate Choice for Repurposing versus SARS-CoV-2?Andrew V Stachulski, Joshua Taujanskas, Sophie L Pate, et al.
Pageof 5